Syneron Medical Ltd
ELOS
ELOS was delisted on the 14th of July, 2017.
65 hedge funds and large institutions have $163M invested in Syneron Medical Ltd in 2016 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 21 increasing their positions, 13 reducing their positions, and 7 closing their positions.
62% more repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 13
0% more funds holding
Funds holding: 65 → 65 (0)
0% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 7
16% less capital invested
Capital invested by funds: $193M → $163M (-$30.3M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
65% less call options, than puts
Call options by funds: $51K | Put options by funds: $145K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CAD
Craig A. Drill
|
+$10.7M |
| 2 |
BIP
Brandes Investment Partners
La Jolla,
California
|
+$4.81M |
| 3 |
Two Sigma Investments
New York
|
+$664K |
| 4 |
Millennium Management
New York
|
+$416K |
| 5 |
D.E. Shaw & Co
New York
|
+$413K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
-$18.2M |
| 2 |
IAM
Ion Asset Management
Herzliya,
Israel
|
-$6.89M |
| 3 |
SAM
Senzar Asset Management
New York
|
-$3.92M |
| 4 |
RA
Royce & Associates
New York
|
-$2.56M |
| 5 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
-$1.74M |
ELOS Hedge Fund Activity: Q3 2016 in Review
65 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Syneron Medical Ltd (ELOS) for Q3 2016, worth a combined $163M — down 16% from $193M a quarter earlier.
Fund positioning in ELOS was balanced in Q3 2016: 7 funds opened new positions, 7 closed out, 21 added to existing stakes and 13 trimmed.
The largest buyer was Craig A. Drill, adding an estimated $10.7M. The largest seller was JP Morgan Chase, cutting an estimated $18.2M.
- 65 institutional investors held Syneron Medical Ltd (ELOS) as of Q3 2016, unchanged from Q2 2016.
- Funds reported $163M of Syneron Medical Ltd stock for Q3 2016, down 16% quarter-over-quarter.
- 7 funds opened new Syneron Medical Ltd positions in Q3 2016 and 7 closed out, a net change of 0 holders.
- The largest Syneron Medical Ltd buyer in Q3 2016 was Craig A. Drill, an estimated $10.7M added.
- The largest Syneron Medical Ltd seller in Q3 2016 was JP Morgan Chase, an estimated $18.2M sold.
Based on aggregated 13F filings for Q3 2016.